Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07735754) titled 'A Step Forward for Unraveling the Immune Mechanisms and Tools for Tuberculosis Spectrum Management' on July 24.
Study Type: Observational [Patient Registry]
Primary Sponsor: Irene Latorre Rueda
Condition:
Tuberculosis
Recruitment Status: Not recruiting
Date of First Enrollment: September 2026
Target Sample Size: 940
To know more, visit https://clinicaltrials.gov/study/NCT07735754
Disclaimer: Curated by HT Syndication....